Market Value2,590,824,056
Total Holdings63
File Date2023-11-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
PACB / Pacific Biosciences of California, Inc.
RPTX / Repare Therapeutics Inc.
DVAX / Dynavax Technologies Corporation
ANAB / AnaptysBio, Inc.
PRTA / Prothena Corporation plc Put
ATXS / Astria Therapeutics, Inc.
SWTX / SpringWorks Therapeutics, Inc.
APGE / Apogee Therapeutics, Inc.
ITCI / Intra-Cellular Therapies, Inc.
FDMT / 4D Molecular Therapeutics, Inc.
NVCR / NovoCure Limited
ALKS / Alkermes plc
MRNA / Moderna, Inc.
HLVX / HilleVax, Inc.
JAZZ / Jazz Pharmaceuticals plc
NRIX / Nurix Therapeutics, Inc.
SLN / Silence Therapeutics plc - Depositary Receipt (Common Stock)
NKTR / Nektar Therapeutics
SRRK / Scholar Rock Holding Corporation
TXG / 10x Genomics, Inc.
ABOS / Acumen Pharmaceuticals, Inc.
AGIO / Agios Pharmaceuticals, Inc.
MORF / Morphic Holding, Inc.
GERN / Geron Corporation
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
ANIP / ANI Pharmaceuticals, Inc.
VIGL / Vigil Neuroscience, Inc.
AMLX / Amylyx Pharmaceuticals, Inc.
PNT / POINT Biopharma Global Inc.
SYRS / Syros Pharmaceuticals, Inc.
CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
BNTX / BioNTech SE - Depositary Receipt (Common Stock)
SLRN / Acelyrin, Inc.
NUVB / Nuvation Bio Inc.
IMUX / Immunic, Inc.
ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
MLTX / MoonLake Immunotherapeutics
INZY / Inozyme Pharma, Inc.
ZNTL / Zentalis Pharmaceuticals, Inc.
FGEN / FibroGen, Inc. Call
INKT / MiNK Therapeutics, Inc.
IPSC / Century Therapeutics, Inc.
NVAX / Novavax, Inc.
ZURA / Zura Bio Limited
VRDN / Viridian Therapeutics, Inc.
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
GHRS / GH Research PLC
PLRX / Pliant Therapeutics, Inc.
IONS / Ionis Pharmaceuticals, Inc.
OLMA / Olema Pharmaceuticals, Inc.
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
IMVT / Immunovant, Inc.
ETNB / 89bio, Inc.
INSM / Insmed Incorporated
NTLA / Intellia Therapeutics, Inc.
AXSM / Axsome Therapeutics, Inc.
EWTX / Edgewise Therapeutics, Inc.
DYN / Dyne Therapeutics, Inc.
GH / Guardant Health, Inc.
TERN / Terns Pharmaceuticals, Inc.
BEAM / Beam Therapeutics Inc.
RAPT / RAPT Therapeutics, Inc.
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
EDIT / Editas Medicine, Inc.
RLMD / Relmada Therapeutics, Inc.
AGEN / Agenus Inc.
ALLK / Allakos Inc.
HRTX / Heron Therapeutics, Inc.
NBIX / Neurocrine Biosciences, Inc.
TVTX / Travere Therapeutics, Inc.